🇧🇪 Belgium Country × Condition
non small cell lung cancer Clinical Trials in Belgium
Active clinical trials for non small cell lung cancer with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇧🇪 Belgium
Active Trials in Belgium (4)
NCT06303505 Phase 1, Phase 2
Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Enrollment
334 pts
Country
🇧🇪 Belgium
Gilead Sciences
View Trial → NCT05933239 Phase 2
Recruiting
Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients
Enrollment
20 pts
Country
🇧🇪 Belgium
Universitair Ziekenhuis Brussel
View Trial → NCT06767514 Phase 3
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Enrollment
780 pts
Country
🇧🇪 Belgium
Summit Therapeutics
View Trial → NCT05061550 Phase 2
Recruiting
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Enrollment
630 pts
Country
🇧🇪 Belgium
AstraZeneca
View Trial → Frequently Asked Questions
How many non small cell lung cancer clinical trials are active in Belgium?
There are currently 4 active clinical trials for non small cell lung cancer with sites in Belgium, of which 4 are actively recruiting patients.
How can I join a non small cell lung cancer clinical trial in Belgium?
To join a non small cell lung cancer clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are non small cell lung cancer trials in Belgium?
Active non small cell lung cancer trials in Belgium span Phase 1, Phase 2, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology